1. Evaluating drug cost per responder and number needed to treat associated with lixisenatide on top of glargine when compared to rapid-acting insulin intensification regimens on top of glargine, in patients with type 2 diabetes in the UK, Italy, and Spain. (3rd June 2017) Authors: Afonso, Marion; Ryan, Fay; Pitcher, Ashley; Lew, Elisheva Journal: Journal of medical economics Issue: Volume 20:Number 6(2017) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗